Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Panagiotis Samaras"'
Autor:
Marcel A. Schneider, Michael Linecker, Ralph Fritsch, Urs J. Muehlematter, Daniel Stocker, Bernhard Pestalozzi, Panagiotis Samaras, Alexander Jetter, Philipp Kron, Henrik Petrowsky, Claude Nicolau, Jean-Marie Lehn, Bostjan Humar, Rolf Graf, Pierre-Alain Clavien, Perparim Limani
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Restoring oxygenation in hypoxic tumors might lead to favorable oncological outcome of patients if combined with standard multimodal therapy regimens. Here the authors report a phase Ib clinical trial of anti-hypoxic myo-inositol trispyrophosphate (I
Externí odkaz:
https://doaj.org/article/cd2ec9ef8ede4523a0cca213868f4458
Autor:
Martin Fehr, Hanne Hawle, Stefanie Hayoz, Peter Thuss-Patience, Sabina Schacher, Jorge Riera Knorrenschild, Donat Dürr, Wolfram T. Knoefel, Holger Rumpold, Michael Bitzer, Martin Zweifel, Panagiotis Samaras, Ulrich Mey, Marc Küng, Ralph Winterhalder, Wolfgang Eisterer, Viviane Hess, Marie-Aline Gérard, Arnoud Templeton, Michael Stahl, Thomas Ruhstaller, for the Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT), the Fédération Francophone de Cancérologie Digestive (FFCD) / Fédération de Recherche en Chirurgie (FRENCH)
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background High rates of venous thromboembolic events (VTEs), mainly in advanced disease, are reported for patients with cancer of the upper gastrointestinal tract (stomach, pancreas) and for treatment with cisplatin. Methods Exploratory ana
Externí odkaz:
https://doaj.org/article/0081a584ac4248f78e6831be4adafd73
Autor:
Paul M. Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, Diana Vetter, Patrick Veit-Haibach, Achim Weber, Peter Bauerfeind, Panagiotis Samaras, Kuno Lehmann
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Pathologic response to neoadjuvant chemotherapy (neoCTX) is a prognostic factor in many cancer types, and early prediction would help to modify treatment. In patients with gastric and esophagogastric junction (AEG) cancer, the acc
Externí odkaz:
https://doaj.org/article/757e57af3ada4b4a991368809d41489d
Autor:
Alexander R. Siebenhüner, Heike Seifert, Helga Bachmann, Burkhardt Seifert, Thomas Winder, Jonas Feilchenfeldt, Stefan Breitenstein, Pierre-Alain Clavien, Roger Stupp, Alexander Knuth, Bernhard Pestalozzi, Panagiotis Samaras
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Biliary tract cancer (BTC) is a dismal disease, even after curative intent surgery. We conducted this prospective, non-randomized phase II study to evaluate the feasibility and efficacy of cisplatin and gemcitabine as adjuvant tre
Externí odkaz:
https://doaj.org/article/5d29d9c60cc24dc8be376eb4754c2f55
Autor:
Panagiotis Samaras, Mario Bargetzi, Daniel C. Betticher, Christoph Driessen, Michel A. Duchosal, Dominik Heim, Nicolas Ketterer, Erika Lerch, Thomas Matthes, Ulrich Mey, Thomas Pabst, Adrian Schmidt, Christian Taverna, Thilo Zander, Christoph Renner
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 1314 (2019)
This update on plasma cell myeloma has been elaborated by a Swiss expert panel as a result of the plethora of new data on the treatment of plasma cell myeloma reported recently. It adds new insights to the more extensive review that was published 3 y
Externí odkaz:
https://doaj.org/article/ccb3fc8bd12844b2b79bfe03d460b9cb
Autor:
Florian Posch, Karina Silina, Sebastian Leibl, Axel Mündlein, Holger Moch, Alexander Siebenhüner, Panagiotis Samaras, Jakob Riedl, Michael Stotz, Joanna Szkandera, Herbert Stöger, Martin Pichler, Roger Stupp, Maries van den Broek, Peter Schraml, Armin Gerger, Ulf Petrausch, Thomas Winder
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Tertiary lymphoid structures (TLS) are associated with favorable outcome in non-metastatic colorectal carcinoma (nmCRC), but the dynamics of TLS maturation and its association with effective anti-tumor immune surveillance in nmCRC are unclear. Here,
Externí odkaz:
https://doaj.org/article/b7a42bdf173b4855b20cfe83ca4088e4
Autor:
Daniel Reding, Bernhard C. Pestalozzi, Stefan Breitenstein, Roger Stupp, Pierre-Alain Clavien, Ksenija Slankamenac, Panagiotis Samaras
Publikováno v:
Swiss Medical Weekly, Vol 147, Iss 3334 (2017)
OBJECTIVES To report survival following different operative strategies and perioperative chemotherapy in patients with synchronous colorectal liver metastases in a tertiary academic referral centre. METHODS We performed a retrospective analysis,
Externí odkaz:
https://doaj.org/article/bbcdb3b4561a4b9791e17e2572951e38
Autor:
Michael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, Silvia Lang, Michael Scharl, Adriano Aguzzi, Derek A Oldridge, John M Maris, Gerhard Rogler
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170851 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0147682.].
Externí odkaz:
https://doaj.org/article/79a12c4aa16946e1a1799a3af612c1ab
Autor:
Sarah Pfrommer, Achim Weber, Philipp Dutkowski, Niklaus G. Schäfer, Beat Müllhaupt, Jean-Pierre Bourquin, Stefan Breitenstein, Bernhard C. Pestalozzi, Frank Stenner, Christoph Renner, Giannicola D'Addario, Hans-Jörg Graf, Alexander Knuth, Pierre-Alain Clavien, Panagiotis Samaras
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 3, Pp 497-503 (2013)
Pancreatic tumors are rare in children and adolescents. Here, we report the case of a 15-year-old boy who presented with a mixed acinar cell carcinoma/ductal adenocarcinoma with blastomatous components. He received multimodal treatment including vari
Externí odkaz:
https://doaj.org/article/c32320a3431c49608c51ef596a4e28da
Autor:
Michael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, Silvia Lang, Michael Scharl, Adriano Aguzzi, Derek A Oldrige, John M Maris, Gerhard Rogler
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147682 (2016)
High-risk neuroblastoma remains lethal in about 50% of patients despite multimodal treatment. Recent attempts to identify molecular targets for specific therapies have shown that Neuroblastoma RAS (NRAS) is significantly mutated in a small number of
Externí odkaz:
https://doaj.org/article/cecc4e5ead3740d186e55e1446fa94fd